The $300 million trial between Dakota Access Pipeline developer and Greenpeace reached the halfway mark on Monday as the company wrapped up its side of the case. Energy Transfer claims Greenpeace ...

Company focuses resources on its most advanced clinical development programs while reducing early-stage research activities Organizational adjustments include a workforce reduction of approximately 50 ...

Precision BioSciences (DTIL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further ...

Zurich, 23 October 2025. Elixion Biotech emerges from stealth, announcing the in-silico validation of five targets via its ...

The Phase 3 data will be presented by Ann Childress, M.D., a leading ADHD specialist and past President of the American ...

In the enterprise sales segment, data chaos is felt especially acutely. The larger the company, the more complex lead management becomes: sources are scattered, information becomes outdated, and ...

SION-719 is the first NBD1 stabilizer being evaluated in people living with cystic fibrosisTopline data expected in ...

The "NanoVibronix Inc. (NAOV) - Product Pipeline Analysis, 2025 Update" has been added to ResearchAndMarkets.com's offering. NanoVibronix's key offerings include advanced pain relief drugs, ultrasound ...

Valink's bsADC technology aims to address key limitations of current ADCs by integrating novel targeting strategies with improved payload delivery. The company is also exploring complementary ...

Exclusive: UAE investment group in talks with ministries and private investors as it targets growth in Saudi Arabia’s ...

Discover why Bristol-Myers Squibb (BMY) is a strong buy in 2024—undervalued, high dividend, and robust strategies for ...

Discover how data engineer Ravi Kiran builds self-healing, metadata-driven ETL pipelines that cut failures, automate schema ...